Clinical trial
Phase I/II Trial: Exogenous Surfactant Administration for Patients With COVID-19
NCT04375735 is registered in ClinicalTrials.gov with London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Trial: Exogenous Surfactant Administration for Patients With COVID-19
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 23, 2020
- Completion date
- October 6, 2021
- Enrollment
- 20 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ards, human, covid-19